Impact of Liver Cirrhosis on Incidence of Dialysis Among Patients with Type 2 Diabetes
Yi‐Jing Sheen(Taichung Veterans General Hospital), Wen‐Chen Tsai(China Medical University), Wayne Huey‐Herng Sheu(National Yang Ming Chiao Tung University), Wei-Yin Kuo(China Medical University), Pei‐Tseng Kung(Asia University)
Cited by 8
Related Papers
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
|The Lancet|2019|640
Konjac Supplement Alleviated Hypercholesterolemia and Hyperglycemia in Type 2 Diabetic Subjects—A Randomized Double-Blind Trial
|Journal of the American College of Nutrition|2003|177